Parlati Francesco 4
4 · Calithera Biosciences, Inc. · Filed Jun 19, 2019
Insider Transaction Report
Form 4
Parlati Francesco
VP, RESEARCH
Transactions
- Exercise/Conversion
Common Stock
2019-06-17$2.64/sh+6,246$16,489→ 42,201 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-06-17−6,246→ 0 totalExercise: $2.64Exp: 2023-12-16→ Common Stock (6,246 underlying)
Footnotes (2)
- [F1]Includes 2500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on each of June 8, 2018, December 10, 2018 and June 10, 2019.
- [F2]1/48th of the Option vests in equal monthly installments beginning January 17, 2014.